New Drug Approved for Early Alzheimer’s
Posted inAlzheimer's Disease Biogen Inc Brain Clinical Trials Dementia Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory Placebos Prices (Fares, Fees and Rates) your-feed-healthcare your-feed-science

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Posted inBiotechnology and Bioengineering Cancer China Cystic Fibrosis Delaware Drugs (Pharmaceuticals) Eli Lilly and Company Factories and Manufacturing GlaxoSmithKline PLC Government Contracts and Procurement House of Representatives Intellectual Property Janssen Pharmaceutica Labor and Jobs Leukemia Massachusetts People's Liberation Army (China) Research Senate Shortages Start-ups Supply Chain Tax Credits, Deductions and Exemptions United States International Relations United States Politics and Government

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.